• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)
SHEN Gang, CHENG Ling, WANG Li-Qiang, ZHANG Li-Hong, SHEN Bao-De, LIAO Wei-Bo, LI Juan-Juan, ZHENG Juan, XU Rong, YUAN Hai-Long. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability[J]. 中国天然药物, 2016, 14(10): 757-768.
引用本文: SHEN Gang, CHENG Ling, WANG Li-Qiang, ZHANG Li-Hong, SHEN Bao-De, LIAO Wei-Bo, LI Juan-Juan, ZHENG Juan, XU Rong, YUAN Hai-Long. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability[J]. 中国天然药物, 2016, 14(10): 757-768.
SHEN Gang, CHENG Ling, WANG Li-Qiang, ZHANG Li-Hong, SHEN Bao-De, LIAO Wei-Bo, LI Juan-Juan, ZHENG Juan, XU Rong, YUAN Hai-Long. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability[J]. Chinese Journal of Natural Medicines, 2016, 14(10): 757-768.
Citation: SHEN Gang, CHENG Ling, WANG Li-Qiang, ZHANG Li-Hong, SHEN Bao-De, LIAO Wei-Bo, LI Juan-Juan, ZHENG Juan, XU Rong, YUAN Hai-Long. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability[J]. Chinese Journal of Natural Medicines, 2016, 14(10): 757-768.

Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability

Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability

  • 摘要: Herpetospermum caudigerum lignans (HTL), one of the potential drugs with anti-hepatitis B virus and hepatoprotective effects, has limited clinical applications because of poor aqueous solubility and low bioavailability. Both herpetrione (HPE) and herpetin (HPN) are the most abundant ingredients in HTL and exhibit weak acidity. The purpose of the present study was to produce dried preparations of HTL (composed of HPE and HPN) nanosuspensions (HTL-NS) with high redispersibility using lyophilization technology. The HTL-NS was prepared by utilizing precipitation-combined homogenization technology based on acid-base neutralization reactions, and critical formulation and process parameters affecting the characteristics of HTL-NS were optimized. The resultant products were characterized by particle size analysis, SEM, XRD, stability, solubility, dissolution and in vivo bioavailability. HTL-NS showed near-spherical-shaped morphology and the size was 243 nm with a narrow PDI value of 0.187. The dried preparations with a relatively large particle size of 286 nm and a PDI of 0.215 were achieved by using 4% (W/V) mannitol as cryoprotectants, and had a better stability at 4 or 25�C for 2 months, compared to HTL-NS. In the in vitro test, the dried preparations showed markedly increased solubility and dissolution velocity. Besides, in the in vivo evaluation, it exhibited significant increases in AUC0-t,Cmax,MRT and a decrease in Tmax, compared to the raw drug. In conclusion, our results provide a basis for the development of a drug delivery system for poorly water-soluble ingredients with pH-dependent solubility.

     

    Abstract: Herpetospermum caudigerum lignans (HTL), one of the potential drugs with anti-hepatitis B virus and hepatoprotective effects, has limited clinical applications because of poor aqueous solubility and low bioavailability. Both herpetrione (HPE) and herpetin (HPN) are the most abundant ingredients in HTL and exhibit weak acidity. The purpose of the present study was to produce dried preparations of HTL (composed of HPE and HPN) nanosuspensions (HTL-NS) with high redispersibility using lyophilization technology. The HTL-NS was prepared by utilizing precipitation-combined homogenization technology based on acid-base neutralization reactions, and critical formulation and process parameters affecting the characteristics of HTL-NS were optimized. The resultant products were characterized by particle size analysis, SEM, XRD, stability, solubility, dissolution and in vivo bioavailability. HTL-NS showed near-spherical-shaped morphology and the size was 243 nm with a narrow PDI value of 0.187. The dried preparations with a relatively large particle size of 286 nm and a PDI of 0.215 were achieved by using 4% (W/V) mannitol as cryoprotectants, and had a better stability at 4 or 25�C for 2 months, compared to HTL-NS. In the in vitro test, the dried preparations showed markedly increased solubility and dissolution velocity. Besides, in the in vivo evaluation, it exhibited significant increases in AUC0-t,Cmax,MRT and a decrease in Tmax, compared to the raw drug. In conclusion, our results provide a basis for the development of a drug delivery system for poorly water-soluble ingredients with pH-dependent solubility.

     

/

返回文章
返回